Dr. María-Victoria Mateos discusses the progression from MGUS to MM, risk stratification for SMM, and clinical trials showing benefits of treating high-risk SMM. Early treatment of SMM is key in her cure roadmap, with two curative approaches in clinical trials.

María-Victoria Mateos discusses evolving management of myeloma & COVID-19, including reducing infection risk, mortality rates of myeloma patients, immunity and thrombogenic potential of COVID-19, managing myeloma patients, repurposing myeloma drugs for COVID-19 treatment, and advancements in CAR-T and bi-specific therapies for multiple myeloma.